Impaired fasting glucose and cardiovascular risk factor clustering among Mongolian population in rural and animal husbandry area, Inner Mongolia, China

Diabetes Research and Clinical Practice

Volumn 89, Issue 3, 2010, Pages 282-287

  Zhang, Shaoyan ^a   Tong, Weijun ^a   Wang, Guiyan ^a,b   Xu, Tan ^a   Zhang, Yonghong ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b Department of Prevention and Care   (China)

Author keywords

Diabetes; Impaired fasting glucose; Risk factor clustering

Indexed keywords

ADULT; AGED; ANIMAL HUSBANDRY; ARTICLE; CARDIOVASCULAR RISK; CHINA; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; RISK ASSESSMENT; RURAL AREA;

EID: 77955430180     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.04.008     Document Type: Article

References (29)

1. Gerstein H.C., Yusuf S. Dysglycaemia and risk of cardiovascular disease. Lancet 1996, 347:949-950.
2. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Bonadonna R., et al. Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diabetes Care 1999, 22:1339-1346.
3. Harris M.I., Eastman R.C. Is there a glycemic threshold for mortality risk?. Diabetes Care 1998, 21:331-333.
4. Donahue R.P., Orchard T.J. Diabetes mellitus and macrovascular complications. An epidemiological perspective. Diabetes Care 1992, 15:1141-1155.
5. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004, 27(Suppl. 1):S5-S10.
6. Unwin N., Shaw J., Zimmet P., Alberti K.G. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet. Med. 2002, 19:708-723.
7. Edelstein S.L., Knowler W.C., Bain R.P., Andres R., Barrett-Connor E.L., Dowse G.K., et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997, 46:701-710.
8. Lorenzo C., Williams K., Hunt K.J., Haffner S.M. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007, 30:8-13.
9. Barr E.L, Zimmet P.Z., Welborn T.A., Jolley D., Magliano D.J., Dunstan D.W., et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007, 116:151-157.
10. Zhang Y.F., Hong J., Zhan W.W., Li X.Y., Gu W.Q., Yang Y.S., et al. Hyperglycaemia after glucose loading is a major predictor of preclinical atherosclerosis in nondiabetic subjects. Clin. Endocrinol. (Oxf) 2006, 64:153-157.
11. Novoa F.J., Boronat M., Saavedra P., Diaz-Cremades J.M., Varillas V.F., La Roche F., et al. Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study. Diabetes Care 2005, 28:2388-2393.
12. Shaw J.E, Zimmet P.Z., de Courten M., Dowse G.K., Chitson P., Gareeboo H., et al. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?. Diabetes Care 1999, 22:399-402.
13. Faeh D., William J., Yerly P., Paccaud F., Bovet P. Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity. Cardiovasc. Diabetol. 2007, 6:32.
14. Gu D., Reynolds K., Duan X., Xin X., Chen J., Wu X., et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003, 46:1190-1198.
15. Zhang S., Tong W., Xu T., Wu B., Zhang Y. Diabetes and impaired fasting glucose in Mongolian population, Inner Mongolia, China. Diab. Res. Clin. Pract. 2009, 86:124-129.
16. Zhou B. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi 2002, 23:5-10.
17. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29(Suppl. 1):S43-S48.
18. Fuchs M., Hoekstra J.B., Mudde A.H. Glucose and cardiovascular risk. Neth. J. Med. 2002, 60:192-199.
19. Kadowaki S., Okamura T., Hozawa A., Kadowaki T., Kadota A., Murakami Y., et al. Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80. Diabetologia 2008, 51:575-582.
20. Valdes S., Botas P., Delgado E., Alvarez F., Cadorniga F.D. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study. Metabolism 2008, 57:399-403.
21. Forouhi N.G., Luan J., Hennings S., Wareham N.J. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet. Med. 2007, 24:200-207.
22. Rijkelijkhuizen J.M., Nijpels G., Heine R.J., Bouter L.M., Stehouwer C.D., Dekker J.M. High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study. Diabetes Care 2007, 30:332-336.
23. Lawes C.M., Parag V., Bennett D.A., Suh I., Lam T.H., Whitlock G., et al. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 2004, 27:2836-2842.
24. Uzunlulu M., Oguz A. Is metabolic syndrome a condition independent of prediabetes and type 2 diabetes mellitus? A report from Turkey. Endocr. J. 2007, 54:745-750.
25. Liu J., Grundy S.M., Wang W., Smith S.C., Vega G.L., Wu Z., et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am. Heart J. 2007, 153:552-558.
26. Abdul-Ghani M.A., Sabbah M., Muati B., Dakwar N., Kashkosh H., Minuchin O., et al. High frequency of pre-diabetes, undiagnosed diabetes and metabolic syndrome among overweight Arabs in Israel. Isreal Med. Assoc. J. 2005, 7:143-147.
27. Boronat M., Varillas V.F., Saavedra P., Suarez V., Bosch E., Carrillo A., et al. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria. Diabet. Med. 2006, 23:148-155.
28. Ye X., Franco O.H., Yu Z., Li H., Hu F.B., Liu H., et al. Associations of inflammatory factors with glycaemic status among middle-aged and older Chinese people. Clin. Endocrinol. (Oxf) 2008.
29. Kaukua J., Turpeinen A., Uusitupa M., Niskanen L. Clustering of cardiovascular risk factors in type 2 diabetes mellitus: prognostic significance and tracking. Diab. Obes. Metab. 2001, 3:17-23.